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The arbovirus California encephalitis virus was first
isolated in 1943 from mosquitoes collected in Kern County,
California (1). Two years later, three human cases of
encephalitis were attributed to this new virus (2); all three
cases were in residents of Kern County in the Central Valley
of California. The best-documented case occurred in a
2-month-old Hispanic boy who had encephalitis and resultant
developmental delay. There was strong laboratory evidence
confirming infection from the presence of neutralizing
antibodies to California encephalitis, but not to St. Louis
encephalitis virus or western equine encephalomyelitis virus.
Serum from a 7-year-old boy hospitalized with encephalitis
also had neutralizing antibodies to California encephalitis.
Serologic tests were inconclusive in a third possible case in a
22-year-old agricultural worker with mild encephalitis;
neutralizing antibodies against both California encephalitis
and St. Louis encephalitis were detected.
Since the original virus was isolated, other viruses have
been isolated that are closely related to California
encephalitis. This group of related viruses is now classified as
the California serogroup, one of 16 serogroups within the
genus  Bunyavirus, family Bunyaviridae. Several other
human pathogens (e.g., Jamestown Canyon virus, La Crosse
virus, and Tahyna virus) also belong to the California
serogroup. Little human disease was associated with these
viruses until 1960, but now California serogroup virus
infections are the most commonly reported cause of arboviral
encephalitis in the United States. From 1996 to 1998,
approximately three times as many reported human cases of
arboviral encephalitis were caused by California serogroup
viruses as were reported for western equine encephalomyeli-
tis virus, St. Louis encephalitis, and eastern equine
encephalomyelitis viruses combined (3). However, since the
three original cases from California, no further cases of
human disease caused by the prototype California
encephalitis had been reported (4). Campbell et al.
summarized results of surveys for human antibodies to
California serogroup viruses in California (5).
Case Report
In June 1996, a 65-year-old man who lived in Marin
County, California, became ill with blurred vision and
dizziness. Eight days after the onset of symptoms, he visited
his primary physician. A physical examination was
remarkable only for nystagmus. Laboratory studies included
leukocytes 8.2x103, hematocrit 45.8%, and a chemistry panel
that was normal except for phosphorus 4.5 mg/dL (normal
range 2.7-4.4 mg/dL), cholesterol 265 mg/dL (normal range
125-200 mg/dL), and high-density lipoprotein cholesterol 67
mg/dL (normal range 35-60 mg/dL). A magnetic resonance
image and arteriogram were normal. One month after the
initial visit, the patient no longer complained of blurred vision
or vertigo, and nystagmus had disappeared. Two years after
the episode, he had no neurologic sequelae.
The patient lived in a suburban area of Marin County,
approximately 1 km from a large brackish marsh bordering
San Francisco Bay. He had traveled outside the United States
the previous February, when he had visited Egypt and several
Caribbean islands. He had not traveled outside California
between this time and the onset of his illness in June, 4
months later.
An acute-phase serum specimen was sent to the Viral and
Rickettsial Disease Laboratory, California Department of
Health Services. Indirect immunofluorescence antibody tests
were negative for St. Louis encephalitis and Western equine
encephalomyelitis virus, as were serum samples taken 8 and
16 days after onset of illness. However, when this series of
samples was tested by neutralization test 2 years later at the
Arbovirus Research Unit of the University of California
Center for Vector-Borne Disease Research as part of a
retrospective study of arboviruses, the 8-day sample showed
an antibody titer of 1:80 and the 16-day sample an antibody
titer < 1:320 to California encephalitis (Table).
California encephalitis-related arboviruses included in
the tests were snowshoe hare, La Crosse, Jamestown Canyon,
Morro Bay, and Tahyna. Tahyna, an important California
serogroup virus widely distributed in Europe and Asia, was
included because of the patient’s travel history. Northway,
Main Drain, and Lokern viruses, members of the
Bunyamwera serogroup occurring in California, were also
included, as were western equine encephalomyelitis virus and
St. Louis encephalitis.
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The sera were tested by plaque reduction-serum dilution
neutralization with African green monkey kidney (Vero) cell
cultures, according to the protocol of Campbell et al. (6). An
increase in titer between the acute- and convalescent-phase
samples was found only for California encephalitis and
snowshoe hare virus. The titers for the convalescent-phase
serum were 1:320 for California encephalitis and 1:180 for the
closely related snowshoe hare virus (Table), which has never
been reported in California. The patient had not traveled
recently to alpine areas of the state, where snowshoe hare
virus might be expected to occur.
Conclusions
Because the patient’s travel occurred several months
before his illness, exposure to mosquitoes near his home is the
most likely route of infection. The most common mosquito
species in salt marshes in Marin County are Aedes washinoi
and Ae. squamiger (7). Bloodsucking adult females of both
these species are usually present in late winter to early
spring. Ae. dorsalis also occurs in this area, but later in the
year. Culiseta inornata occurs frequently near salt marshes.
California encephalitis has not been recovered from any of
these species in California; most isolates have come from Ae.
melanimon in the Central Valley (8).
Campbell et al. (5) found that most seropositive samples
from humans, mostly from high elevations (>1,000 m) in
California, were apparently infected with Jamestown Canyon
virus. However, these investigators also reported that
approximately 35% of samples from horses in low elevations
(<1,000 m) in California showed evidence of prior infection
with California encephalitis (9), but they did not test samples
from the San Francisco Bay area. Fulhorst et al. (10) reported
that 57% of the horses sampled in Marin County showed
evidence of prior infection with Jamestown Canyon virus, but
none with California encephalitis.
Awareness of arboviruses in the United States has been
heightened as a result of the recent outbreak of human
illnesses caused by West Nile virus. That outbreak was
originally thought to be due to St. Louis encephalitis (11). The
case we describe is a further reminder that clinicians should
consider several causative agents when a patient has a
central nervous system infection, especially if mosquito
exposure has occurred.
Further studies are needed to assess the risk for human
infection by California encephalitis in coastal California and
the role of various mosquito species in transmission.
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Table. Neutralizing antibody titers to 10 arboviruses in paired serum
samples of a patient with neurologic symptoms, California, 1996
Acute-phase Convalescent-
Virus (strain)     seruma phase serumb
California encephalitis   1:80   1:320
 (BFS-283)
Snowshoe hare (original)   1:80   1:160
La Crosse (prototype)   1:40   1:40
Jamestown Canyon   1:20   1:20
  (BFS 4474)
Morro Bay (DAV 457)   1:80   1:40
Tahyna (Bardos 92)   1:40   1:20
Northway (BFN 2654)   1:20 <1:20
Main Drain (BFS 5015) <1:20 <1:20
Lokern (BFS 5183) <1:20 <1:20
Western equine encephalo- <1:20 <1:20
  myelitis (BFS 1703)
St. Louis encephalitis <1:20 <1:20
  (BFS 1750)
aSample taken 8 days after onset of symptoms.
bSample taken 16 days after onset of symptoms.